Phase
Condition
Labor/delivery
Treatment
Pulsenmore ES home ultrasound device
Clinical Study ID
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥ 18 years old
Singleton pregnancy
Gestational age ≥ 24 0/7 weeks
No known major fetal or genetic anomalies (may include: isolated pyelectasis,isolated --VSD, multicystic dysplastic kidney, cleft lip/palate, club foot, etc.)
Ability to understand and sign informed consent in English
Ability to read and understand instructions in English
Ability to hold an ultrasound probe and respond to clinician instructions
BMI less than 40 at initial prenatal visit
Scheduled biophysical profile (BPP)
Any maternal/pregnancy complications requiring antenatal testing, including but notlimited to intrauterine growth restriction, chronic or gestational hypertension,preexisting or gestational diabetes, autoimmune disorder, etc.
Exclusion
Exclusion Criteria:
Multiple gestation
Known major fetal structural anomaly or aneuploidy
Known fetal or genetic anomalies
Ruptured membranes
Uterine complaints, such as painful contractions
Maternal concern for decreased fetal movement
Not evaluated vaginal bleeding (not including spotting)
Fetal or maternal criteria that require urgent delivery
BMI ≥ 40 at initial prenatal visit
Study Design
Connect with a study center
University of Michigan
Ann Arbor, Michigan 48109
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.